03-21-2003: Innovative tools that debottleneck drug discovery are critical in the race for new medical therapies. As sample sizes get smaller and more numerous, the effectiveness of the screening process can either facilitate the discovery of a life-saving drug or contribute to its failure. A new sample preparation tool from Pall Corporation (NYSE: PLL) enables laboratories to process hundreds of samples simultaneously speeding the way toward new medical therapies. The AcroPrep(TM) 384 multi-well filter plate optimizes the identification of novel leads and targets for drug development. The enabling technology is used in countless DNA and protein sample preparation and detection processes.
The AcroPrep 384 multi-well filter plate helps scientists quickly and reliably sift through thousands of drug targets in the search for those with promise. Using a patented technology, the AcroPrep 384 multi-well filter plate eliminates lateral cross contamination, or "crosstalk", that can slow down the screening process. Crosstalk occurs when the signal from one well inadvertently enters adjacent wells. The new Pall plate eliminates this confounding problem by individually sealing each well so signals cannot travel from one to the other. By eliminating crosstalk, laboratories can reliably process 384 samples in minutes, increase output and identify promising drug targets to treat diseases.
"New sample preparation technologies that deliver pure, undamaged DNA and protein are critical to advance drug discovery, genomics and proteomics," said Ken Harris, President of Pall BioSciences. "The AcroPrep 384 multi-well filter plate enables scientists to quickly purify experimental samples in their quest to explore how proteins and nucleic acids might influence or treat certain disease states."
The AcroPrep 384 multi-well filter plate's rigid one-piece construction is ideal for high-volume robotic applications. The design assures that the filter plates do not flex and jam in liquid handling robots.
The unique "square to round" well design of the AcroPrep 384 multi-well filter plate reduces sample hold-up. When molecular biologists work with extremely small sample volumes, they can become "trapped" in the corners of square-bottomed wells. Trapped samples often prevent users from automating their process.
The move to higher throughput, lower volume formats necessary to speed the rate of drug discovery led Pall to develop a broad new line of multi-well filter plates. Pall's multi-well filter plates are available in 96 and 384 well formats and are offered with multiple membrane options and well volumes to meet various application needs.
Watchlist
This is where you can add this news to your personal favourites
Pall Corporation announced the election of Dennis Longstreet to the Company's Board of Directors on July 18, 2006. Mr. Longstreet will be a nominee for re-election on the Company's proxy for the annual meeting of shareholders in November.
Mr. Longstreet, 60, was a Company Group Chairman fo ... more
Pall Corporation and zeta Holding GmbH announced that they have entered into an agreement to collaborate in the use of specific automation software and development, supply and marketing of equipment packages for fermentation, recovery and purification of biotech products.
Under the terms ... more
Pall Corporation announced that is has acquired Euroflow (UK). The company is one of the world's leading manufacturers of pilot and production scale chromatography columns for the biotechnology industry. Pall held exclusive global marketing and distribution rights to Euroflow chromatography ... more
Porous filter ceramics manufactured by Pall Schumacher, used in world-wide applications for the filtration of gases and liquids. Our quality standards are valued and demanded by our customers. more
Pall Corporation is the largest and most diverse filtration, separations and purifications company in the world. Our technical expertise, product portfolio and global reach are unmatched. This diversity is a considerable strength. It enables us to leverage opportunities across industries an ... more
The life sciences industry is both driven and united by its need for speed to market, product reliability and economics. Pall’s leading edge filtration, separation and purification technologies and services play an essential and pivotal role in this industry’s ability to achieve these goals ... more